Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection. (2022)
Attributed to:
Development of a natural transmission model of COVID-19
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v14050976
PubMed Identifier: 35632718
Publication URI: http://europepmc.org/abstract/MED/35632718
Type: Journal Article/Review
Volume: 14
Parent Publication: Viruses
Issue: 5
ISSN: 1999-4915